| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0892-0362(00)00113-6 |
| P698 | PubMed publication ID | 11274873 |
| P50 | author | Michael T. Williams | Q42788926 |
| P2093 | author name string | Vorhees CV | |
| Morford LL | |||
| Inman-Wood SL | |||
| McCrea AE | |||
| P2860 | cites work | Neurotoxic effects of substituted amphetamines in rats and mice | Q26160333 |
| Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 | ||
| Active drug metabolites. An overview of their relevance in clinical pharmacokinetics | Q34557926 | ||
| Paradoxical effects of adrenal steroids on the brain: protection versus degeneration. | Q36763836 | ||
| Neurobiology of an anorectic drug: fenfluramine | Q39739956 | ||
| Corticosteroid Inhibition of ACTH Secretion* | Q40141045 | ||
| Hyperthermia-enhanced serotonin (5-HT) depletion resulting from D-fenfluramine (D-Fen) exposure does not evoke a glial-cell response in the central nervous system of rats | Q40631469 | ||
| Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response | Q40643389 | ||
| The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine | Q40681623 | ||
| Effects of pro-opiomelanocortin peptides on adrenocortical steroidogenesis | Q40853353 | ||
| Role for Brain Corticotropin-Releasing Factor in the Weight-Reducing Effects of Chronic Fenfluramine Treatment in Rats* | Q41129309 | ||
| Central hypertensive effects of aldosterone | Q41621716 | ||
| Direct Inhibitory Effect of Glucocorticoids upon Testicular Luteinizing Hormone Receptor and Steroidogenesis in Vivoa nd in Vitro | Q42451333 | ||
| Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine | Q42538036 | ||
| Involvement of corticotropin-releasing hormone and endogenous opioid peptides in prolactin-suppressed gonadotropin-releasing hormone release in vitro | Q44337138 | ||
| Effects of pretreatment with dexfenfluramine and fluoxetine on metoclopramide-induced aldosterone secretion in healthy volunteers | Q46265398 | ||
| Plasma adrenocorticotropin is more sensitive than transcortin production or thymus weight to inhibition by corticosterone in rats | Q47192491 | ||
| Glucocorticoid-induced impairment in declarative memory performance in adult humans | Q48142295 | ||
| d-Fenfluramine produces neuronal degeneration in localized regions of the cortex, thalamus, and cerebellum of the rat. | Q48208841 | ||
| Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats. | Q48367827 | ||
| GnRH release from the mediobasal hypothalamus: in vitro inhibition by corticotropin-releasing factor | Q48415645 | ||
| Single- and multiple-dose kinetics of d-fenfluramine in rats given anorectic and toxic doses | Q48533689 | ||
| Serotonergic stimulation of pituitary-adrenocortical activity in rats: evidence for multiple sites of action | Q48669333 | ||
| Involvement of corticotrophin releasing factor (CRF) in the thermogenic and anorexic actions of serotonin (5-HT) and related compounds | Q48675102 | ||
| Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. | Q48729923 | ||
| Role of serotonin in the control of secretion of corticotrophin releasing factor | Q48950150 | ||
| Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion | Q48967282 | ||
| The effect of repeated amphetamine and cocaine administration on adrenal, gonadal and thyroid hormone levels in the rat plasma. | Q51581681 | ||
| Preweaning treatment with methamphetamine induces increases in both corticosterone and ACTH in rats. | Q52022761 | ||
| Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. | Q52039149 | ||
| A long-term increase in basal levels of corticosterone and a decrease in corticosteroid-binding globulin after acute stressor exposure | Q60686597 | ||
| Corticosterone response to the serotonergic agonist d-fenfluramine may be independent from corticotropin-releasing factor (CRF) | Q61479745 | ||
| Effect of Amphetamine on Plasma Corticosterone in the Conscious Rat | Q66966364 | ||
| Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotropin-releasing factor | Q68091022 | ||
| Amphetamine or haloperidol 2 weeks earlier antagonized the plasma corticosterone response to amphetamine; evidence for the stressful/foreign nature of drugs | Q68177364 | ||
| In vitro effects of ACTH, angiotensins, serotonin and potassium on steroid output and conversion of corticosterone to aldosterone by isolated adrenal cells | Q68617825 | ||
| Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation | Q68928184 | ||
| Chronic methamphetamine and its withdrawal modify behavioral and neuroendocrine circadian rhythms | Q69087373 | ||
| Temporal changes in prolactin and corticosterone response during chronic treatment with d-fenfluramine | Q69750822 | ||
| Effects of Angiotensin II, K+, Adrenocorticotropin, Serotonin, Adenosine 3′,5′-Monophosphate, Guanosine 3′,5′-Monophosphate, A23187, and EGTA on Aldosterone Synthesis and Phospholipid Metabolism in the Rat Adrenal Zona Glomerulosa* | Q70163575 | ||
| Evidence for ACTH-unrelated mechanisms in the regulation of cortisol secretion in man | Q70192848 | ||
| Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man | Q70306983 | ||
| Pituitary-adrenal axis responses to acute amphetamine in the rat | Q70465842 | ||
| Effect of serotonin-releasing drugs on serum corticosterone concentration in rats | Q70528625 | ||
| Chronic social stress produces reductions in available splenic type II corticosteroid receptor binding and plasma corticosteroid binding globulin levels | Q71460841 | ||
| Hormonal responses to d- and d,l-fenfluramine in healthy human subjects | Q71840207 | ||
| Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions | Q72636265 | ||
| Inhibition of corticosteroid-binding globulin caused by a severe stressor is apparently mediated by the adrenal but not by glucocorticoid receptors | Q73514272 | ||
| P433 | issue | 1 | |
| P921 | main subject | testosterone | Q27863114 |
| P304 | page(s) | 23-32 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Neurotoxicology and Teratology | Q15097918 |
| P1476 | title | Elevations in plasmatic titers of corticosterone and aldosterone, in the absence of changes in ACTH, testosterone, or glial fibrillary acidic protein, 72 h following D,L-fenfluramine or D-fenfluramine administration to rats | |
| P478 | volume | 23 |
| Q44235442 | Administration of D,L-fenfluramine to rats produces learning deficits in the Cincinnati water maze but not the Morris water maze: relationship to adrenal cortical output |
| Q33941234 | Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse. |
| Q44112608 | Impaired spatial and sequential learning in rats treated neonatally with D-fenfluramine |
| Q46549768 | Platelet monoamine oxidase B (MAO-B) activity and its relationship to DL-fenfluramine-induced prolactin response in healthy men. |
Search more.